Tevogen Bio Holdings Inc. (TVGNW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 30Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29

Key dataOct 29, 2026

Open$0.05

From 52W high−12.43%

Volume808244.00

Market cap$14.51M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 29, 2026

Open

$0.05

From 52W high

−12.43%

Volume

808244.00

Market cap

$14.51M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−0.9x

P/E (TTM)

—

RSI (14)

63.3

MomentumView details →

1D Return

−12.43%

YTD Return

+89.57%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−0.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−1.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

243.15%

ROA (TTM)

−457.14%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+36.07%

FCF YoY

+12.85%

Revenue CAGR 3Y

—

EPS CAGR 3Y

−72.65%

EBITDA YoY

+31.99%

MomentumView details →

1D Return

−12.43%

YTD Return

+89.57%

1Y Return

+58.10%

RSI (14)

63.3

vs 50D SMA

+32.62%

vs 200D SMA

+69.55%

Capital & dividendView details →

Debt/Equity

−0.34x

Current Ratio

0.33x

Quick Ratio

0.33x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$1.52

EPS Surprise

40.04%

Beats (12Q)

4/12

Next Q EPS Est

−$2.41

Avg Surprise (4Q)

32.75%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−21.61M

Op. CF (TTM)

−11.57M

Next earningsNov 24, 2026 →

Latest newsMore news →

Tevogen signed a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of HRK Healthcare LLC.22d ago

Tevogen Inc. granted CEO and board chair Ryan Saadi 8,000,000 restricted shares and CFO Kirti Desai 750,000 restricted shares, effective September 14, 2026.44d ago

Similar companies

Dyadic International, Inc.DYAI Allarity Therapeutics, Inc.ALLR Pluri Inc.PLUR Bolt Biotherapeutics, Inc.BOLT BioCardia, Inc.BCDA Psyence Biomedical Ltd.PBM Find similar companies →

Latest newsMore news →

Tevogen signed a non-exclusive, non-binding letter of intent to evaluate a potential acquisition of HRK Healthcare LLC.22d ago Tevogen Inc. granted CEO and board chair Ryan Saadi 8,000,000 restricted shares and CFO Kirti Desai 750,000 restricted shares, effective September 14, 2026.44d ago